Young women with breast cancer tend to have more advanced tumor TNM staging, more invasive pathological type, higher tumor grade, higher lymph node positivity, higher proportion of triple-negativity, higher HER2 expression and lower ER/PR positivity [13–22]. The gene discussed is ESR1; the disease is neoplasm.